Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abeona Therapeutics Inc. - Common Stock
(NQ:
ABEO
)
4.760
-0.190 (-3.84%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abeona Therapeutics Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
The Law Offices of Frank R. Cruz Announces Investigation of Abeona Therapeutics Inc. (ABEO) on Behalf of Investors
April 29, 2024
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Crude Oil Moves Higher; General Motors Earnings Top Views
↗
April 23, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
April 23, 2024
Via
Benzinga
Dow Jumps Over 200 Points; US Services PMI Falls In April
↗
April 23, 2024
Via
Benzinga
Topics
Stocks
Recap: Abeona Therapeutics Q3 Earnings
↗
November 13, 2023
Via
Benzinga
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
April 23, 2024
Via
Benzinga
Why Is Affirm (AFRM) Stock Moving Today?
↗
April 23, 2024
Affirm stock is falling on Tuesday as AFRM investors react to BNPL loan service One being added to Walmart's retail stores.
Via
InvestorPlace
US Stocks Higher; PepsiCo Posts Upbeat Earnings
↗
April 23, 2024
Via
Benzinga
FDA Rejects Approval Of Abeona Therapeutics' Skin Disorder Treatment, Shares Sink
↗
April 23, 2024
Abeona Therapeutics' pz-cel gets the FDA's Complete Response Letter and Abeona's plans for fulfilling Chemistry Manufacturing and Controls requirements.
Via
Benzinga
Why Is Greenwave Technology Solutions (GWAV) Stock Down 47% Today?
↗
April 23, 2024
Greenwave Technology Solutions stock is down on Tuesday as GWAV investors react to a registered direct offering and private placement.
Via
InvestorPlace
Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?
↗
April 23, 2024
Abeona Therapeutics stock is falling on Tuesday after the FDA sent it a CRL for more CMC data before it would approve Pz-cel.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
April 23, 2024
Via
Benzinga
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
↗
April 23, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
↗
April 23, 2024
We're diving into the biggest pre-market stock movers that traders are going to want to keep an eye on for Tuesday morning!
Via
InvestorPlace
Calix Reports Mixed Results, Joins Cadence Design Systems And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
April 23, 2024
Via
Benzinga
Abeona Therapeutics Provides Regulatory Update on Pz-cel
April 22, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 01, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
March 19, 2024
Via
Benzinga
ABEO Stock Earnings: Abeona Therapeutics Misses EPS for Q4 2023
↗
March 19, 2024
ABEO stock results show that Abeona Therapeutics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
March 18, 2024
- FDA completed Pre-License Inspection of Abeona’s Cleveland manufacturing facility, as well as inspection of clinical trial sites for pz-cel pivotal Phase 3 VIITAL™ study -
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 05, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Processa Pharmaceuticals And 2 Other Penny Stocks Insiders Are Buying
↗
February 08, 2024
The Dow Jones index closed higher by around 150 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
February 07, 2024
Via
Benzinga
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 01, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
February 01, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces $50 Million Credit Facility
January 08, 2024
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 15, 2023
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
November 27, 2023
Via
Benzinga
Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)
November 27, 2023
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments
November 13, 2023
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
